Antimicrobial Resistance (AMR): Surveillance, Policy, and Systems to Slow the Spread

Antimicrobial resistance (AMR) is one of the most urgent public health threats of our time. As bacteria, viruses, and fungi evolve to resist the drugs we rely on, routine care—from childbirth to chemotherapy to simple surgeries—is becoming riskier. This is not a future problem. AMR is already here, reshaping infection control, hospital policy, food safety, and global health security.

Through case studies, systems-level insights, and policy work, Dr. Jay Varma documents how resistance spreads—and how it can be slowed. This hub brings together his most practical writing on AMR surveillance, infection prevention, and public health infrastructure, both in the U.S. and globally. If you’re working in infection control, health systems planning, or global health strategy, start here.

Sub-Clusters

Antimicrobial Resistance in Communities and Hospitals

Drug resistance doesn’t stay in hospitals—it moves through supply chains, communities, and under-regulated food systems. These articles explore where surveillance is breaking down, and what’s needed to rebuild it.

Hospital-Acquired Infections and Infection Control

AMR thrives in clinical settings where airborne, waterborne, or surface-based pathogens can move between patients. These essays explore how stronger design, standards, and oversight reduce hospital-acquired infections.

Global and Policy Perspectives on AMR

Drug resistance doesn’t stop at borders. Global health strategy requires cross-border surveillance, data-sharing, and shared investments. These publications cover what works—and what’s still missing—in global AMR planning.

Why This Hub Matters

Antimicrobial resistance isn’t a niche threat—it’s a systems challenge that cuts across sectors: food, water, ventilation, staffing, labs, and policy. These articles show how public health infrastructure, surveillance design, and global coordination must evolve to meet this moment. Surveillance gaps become blind spots. Funding gaps become hospital outbreaks. Policy gaps become global setbacks.

To protect progress in surgery, cancer treatment, transplant medicine, and infection control, we need a globally coordinated—and locally executed—strategy for AMR. That starts with understanding how resistance spreads, how systems fail, and where we can act faster to protect lives.

Frequently Asked Questions

  • What is antimicrobial resistance, and why does it matter for public health?
  • How does food safety relate to antibiotic resistance?
  • What role do public health labs play in AMR surveillance?
  • How are hospitals addressing the rise of resistant infections?
  • What global strategies exist to control AMR—and where are the gaps?

Navigate Back

← Back to Public Health Explained Hub

Related Hubs